Neuroprotective Effects of Sigma 1 Receptor Ligands on Motoneuron Death after Spinal Root Injury in Mice.
endoplasmic reticulum stress
motoneuron death
sigma-1 receptor
spinal root injury
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
28 Jun 2021
28 Jun 2021
Historique:
received:
07
06
2021
revised:
22
06
2021
accepted:
24
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
8
2021
Statut:
epublish
Résumé
Loss of motor neurons (MNs) after spinal root injury is a drawback limiting the recovery after palliative surgery by nerve or muscle transfers. Research based on preventing MN death is a hallmark to improve the perspectives of recovery following severe nerve injuries. Sigma-1 receptor (Sig-1R) is a protein highly expressed in MNs, proposed as neuroprotective target for ameliorating MN degenerative conditions. Here, we used a model of L4-L5 rhizotomy in adult mice to induce MN degeneration and to evaluate the neuroprotective role of Sig-1R ligands (PRE-084, SA4503 and BD1063). Lumbar spinal cord was collected at 7, 14, 28 and 42 days post-injury (dpi) for immunohistochemistry, immunofluorescence and Western blot analyses. This proximal axotomy at the immediate postganglionic level resulted in significant death, up to 40% of spinal MNs at 42 days after injury and showed markedly increased glial reactivity. Sig-1R ligands PRE-084, SA4503 and BD1063 reduced MN loss by about 20%, associated to modulation of endoplasmic reticulum stress markers IRE1α and XBP1. These pathways are Sig-1R specific since they were not produced in Sig-1R knockout mice. These findings suggest that Sig-1R is a promising target for the treatment of MN cell death after neural injuries.
Identifiants
pubmed: 34203381
pii: ijms22136956
doi: 10.3390/ijms22136956
pmc: PMC8269081
pii:
doi:
Substances chimiques
Neuroprotective Agents
0
Receptors, sigma
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Ministerio de Ciencia, Innovación y Universidades
ID : RTI2018-096386-B-I00
Organisme : Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
ID : CB06/05/1105
Organisme : TERCEL
ID : RD16/0011/0014
Références
Nat Rev Neurol. 2017 Aug;13(8):477-491
pubmed: 28731040
J Neuropathol Exp Neurol. 2018 Jul 1;77(7):577-597
pubmed: 29767748
Neuroscience. 2009 Aug 4;162(1):31-8
pubmed: 19345724
Hand Clin. 2005 Feb;21(1):71-82
pubmed: 15668067
J Neurotrauma. 2009 May;26(5):763-79
pubmed: 19331524
J Comp Neurol. 1994 Apr 1;342(1):35-44
pubmed: 8207127
Neuroscience. 2016 Aug 4;329:213-25
pubmed: 27185485
J Neurotrauma. 2011 May;28(5):831-40
pubmed: 21332255
Clin Neurophysiol. 2011 Aug;122(8):1660-70
pubmed: 21354365
Neurotherapeutics. 2012 Oct;9(4):814-26
pubmed: 22935988
Eur J Neurosci. 2016 Feb;43(3):318-35
pubmed: 26415525
Neurosci Lett. 2014 Jan 24;559:174-8
pubmed: 24334165
Exp Neurol. 1993 Sep;123(1):147-56
pubmed: 8405274
Dev Neurosci. 2015;37(1):66-77
pubmed: 25592862
J Neurotrauma. 2010 Dec;27(12):2273-82
pubmed: 20939695
Hand Clin. 2016 May;32(2):103-17
pubmed: 27094884
Biosci Rep. 2017 Jul 16;37(4):
pubmed: 28667101
Brain. 2019 Feb 1;142(2):295-311
pubmed: 30649249
Br J Pharmacol. 2021 Mar;178(6):1336-1352
pubmed: 32761823
Neuroscience. 2019 Apr 15;404:510-518
pubmed: 30731156
Front Neurol. 2016 Aug 23;7:135
pubmed: 27602018
Cells. 2019 May 21;8(5):
pubmed: 31117227
Brain Res Bull. 2020 Nov;164:184-197
pubmed: 32866558
Neuroscience. 2016 Sep 7;331:148-57
pubmed: 27339730
Sci Rep. 2016 Feb 24;6:21709
pubmed: 26906090
Neuroscience. 2017 Sep 17;359:105-118
pubmed: 28723387
Ann Neurol. 2010 Nov;68(5):639-49
pubmed: 21031579
Elife. 2021 May 11;10:
pubmed: 33973848
Prog Neurobiol. 2007 Jul;82(4):163-201
pubmed: 17643733
Neuroscience. 2013 Oct 10;250:715-32
pubmed: 23896572
Neuropharmacology. 2016 Dec;111:34-46
pubmed: 27567941
Eur J Neurosci. 2003 Oct;18(8):2188-96
pubmed: 14622179
PLoS One. 2013 Oct 18;8(10):e76941
pubmed: 24204710
Neuroscience. 2010 May 5;167(2):247-55
pubmed: 20167253
Sci Rep. 2017 Jan 09;7:40155
pubmed: 28065942
Neurobiol Dis. 2014 Feb;62:218-32
pubmed: 24141020
Invest Ophthalmol Vis Sci. 2020 Nov 2;61(13):3
pubmed: 33137196
Pharmacol Res. 2021 Jan;163:105339
pubmed: 33276102
Acta Myol. 2018 May 01;37(1):2-4
pubmed: 30079398
Neuroscience. 2014 Dec 26;283:138-65
pubmed: 25168733
Sci Rep. 2017 Sep 20;7(1):12028
pubmed: 28931824
J Neurotrauma. 2004 Jan;21(1):95-108
pubmed: 14987469
Ann Neurol. 2011 Dec;70(6):913-9
pubmed: 21842496
Exp Neurol. 2014 Nov;261:367-76
pubmed: 24873730
Neuroscience. 2013 Jun 14;240:129-34
pubmed: 23458708
Curr Neurovasc Res. 2006 May;3(2):89-98
pubmed: 16719792
Cell Death Dis. 2018 May 10;9(5):531
pubmed: 29748539
Neurobiol Dis. 2016 Nov;95:168-78
pubmed: 27461051
Cell Death Dis. 2019 Mar 1;10(3):210
pubmed: 30824685
Int J Mol Sci. 2018 Sep 18;19(9):
pubmed: 30231518
Exp Brain Res. 2001 Jul;139(2):216-23
pubmed: 11497064
Eur J Neurosci. 2001 Jan;13(1):113-8
pubmed: 11135009
Exp Neurol. 2010 May;223(1):207-20
pubmed: 19646436
Neurochem Int. 2017 Sep;108:332-342
pubmed: 28522413
Neurology. 2015 Jun 16;84(24):2430-7
pubmed: 26078401
Cell Death Differ. 2011 Oct;18(10):1617-27
pubmed: 21436843